Harpal Singh Mangat, Age 6511707 Greenlane Dr, Potomac, MD 20854

Harpal Mangat Phones & Addresses

11707 Greenlane Dr, Potomac, MD 20854 (301) 765-0448

11508 Gainsborough Rd, Potomac, MD 20854

11508 Mannakee St, Rockville, MD 20847

521 Mannakee St, Rockville, MD 20850

Gaithersburg, MD

Bala Cynwyd, PA

Clarksburg, MD

Drexel Hill, PA

Upper Darby, PA

Show more

Work

Company: Clarksburg Medical Center Address: 23208 Brewers Tavern Way, Clarksburg, MD 20871 Phones: (301) 515-3333 (Phone)

Education

School / High School: Royal College Of Surgeons In Ireland Med School National University Of Ireland

Languages

English

Mentions for Harpal Singh Mangat

Career records & work history

Medicine Doctors

Harpal Mangat Photo 1

Dr. Harpal S Mangat, Clarksburg MD - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
Clarksburg Medical Center
23208 Brewers Tavern Way, Clarksburg, MD 20871
(301) 515-3333 (Phone)
Medical Center Of Frederick
186 Thomas Johnson Dr Suite 105, Frederick, MD 21702
(301) 662-0967 (Phone)
Languages:
English
Hospitals:
Clarksburg Medical Center
23208 Brewers Tavern Way, Clarksburg, MD 20871
Medical Center Of Frederick
186 Thomas Johnson Dr Suite 105, Frederick, MD 21702
Frederick Memorial Hospital
400 West 7Th Street, Frederick, MD 21701
Shady Grove Adventist Hospital
9901 Medical Center Drive, Rockville, MD 20850
Education:
Medical School
Royal College Of Surgeons In Ireland Med School National University Of Ireland

Harpal S. Mangat

Specialties:
Internal Medicine, Ophthalmology
Work:
Clarksburg Medical Center
22616 Gtwy Ctr Dr STE 600A, Clarksburg, MD 20871
(301) 515-3333 (phone) (301) 515-3322 (fax)
Medical Center Of Frederick
186 Thomas Johnson Dr STE 105, Frederick, MD 21702
(301) 662-0967 (phone) (301) 515-3322 (fax)
Education:
Medical School
Royal Coll of Surgeons in Ireland, Med Sch, Dublin, Ireland
Graduated: 1985
Procedures:
Continuous EKG, Electrocardiogram (EKG or ECG), Pulmonary Function Tests, Vaccine Administration
Conditions:
Abdominal Hernia, Abnormal Vaginal Bleeding, Acne, Acute Bronchitis, Acute Conjunctivitis, Acute Pancreatitis, Acute Pharyngitis, Acute Sinusitis, Acute Upper Respiratory Tract Infections, Alcohol Dependence, Alopecia Areata, Anemia, Anxiety Phobic Disorders, Atherosclerosis, Attention Deficit Disorder (ADD), Benign Prostatic Hypertrophy, Bipolar Disorder, Bronchial Asthma, Calculus of the Urinary System, Candidiasis, Cardiac Arrhythmia, Cardiomyopathy, Carpel Tunnel Syndrome, Celiac Disease, Cholelethiasis or Cholecystitis, Chronic Bronchitis, Cirrhosis, Constipation, Contact Dermatitis, Dehydration, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Diverticulitis, Diverticulosis, Emphysema, Endocarditis, Endometriosis, Erectile Dysfunction (ED), Esophagitis, Femoral Hernia, Fractures, Dislocations, Derangement, and Sprains, Gastritis and Duodenitis, Gastroesophageal Reflux Disease (GERD), Gingival and Periodontal Diseases, Hearing Loss, Heart Failure, Hemolytic Anemia, Hemorrhoids, Herpes Simplex, Herpes Zoster, HIV Infection, Hypertension (HTN), Hypothyroidism, Infectious Liver Disease, Inguinal Hernia, Insomnia, Internal Derangement of Knee Cartilage, Intestinal Obstruction, Ischemic Heart Disease, Ischemic Stroke, Lyme Disease, Malignant Neoplasm of Female Breast, Menopausal and Postmenopausal Disorders, Migraine Headache, Mitral Valvular Disease, Multiple Sclerosis (MS), Non-Toxic Goiter, Obstructive Sleep Apnea, Osteoarthritis, Osteoporosis, Otitis Media, Overweight and Obesity, Pelvic Inflammatory Disease (PID), Peripheral Nerve Disorders, Plantar Fascitis, Plantar Warts, Pneumonia, Prostatitis, Psoriasis, Pulmonary Embolism, Restless Leg Syndrome, Rheumatoid Arthritis, Rosacea, Sarcoidosis, Schizophrenia, Sciatica, Scoliosis or Kyphoscoliosis, Sexually Transmitted Diseases (STDs), Skin and Subcutaneous Infections, Spinal Stenosis, Substance Abuse and/or Dependency, Thyroiditis, Tinea Unguium, Transient Cerebral Ischemia, Urinary Incontinence, Valvular Heart Disease, Varicose Veins, Venous Embolism and Thrombosis, Vitamin B12 Deficiency Anemia, Vitamin D Deficiency
Languages:
English, Spanish
Description:
Dr. Mangat graduated from the Royal Coll of Surgeons in Ireland, Med Sch, Dublin, Ireland in 1985. He works in Frederick, MD and 1 other location and specializes in Internal Medicine and Ophthalmology. Dr. Mangat is affiliated with Adventist Healthcare Shady Grove Medical Center and Frederick Memorial Hospital.
Harpal Mangat Photo 2

Harpal Singh Mangat, Gaithersburg MD

Specialties:
Emergency Medicine Physician
Address:
344 Main St, Gaithersburg, MD 20878
186 Thomas Johnson Dr, Frederick, MD 21702
23208 Brewers Tavern Way, Clarksburg, MD 20871

Harpal Mangat resumes & CV records

Resumes

Harpal Mangat Photo 13

Harpal Mangat

Harpal Mangat Photo 14

Owner, Clarksburg Medical Center

Position:
Owner at clarksburg medical center
Location:
Washington D.C. Metro Area
Industry:
Hospital & Health Care
Work:
clarksburg medical center
Owner
Education:
The Royal College of Physicians in Ireland 1979 - 1985

Publications & IP owners

Us Patents

Method Of Treating An Ocular Disease And Compositions Effective For Treating An Ocular Disease

US Patent:
2014004, Feb 13, 2014
Filed:
Oct 21, 2013
Appl. No.:
14/059035
Inventors:
Harpal S. Mangat - Washington DC, US
Assignee:
HOWARD UNIVERSITY - Washington DC
International Classification:
A61K 38/13
US Classification:
514 12
Abstract:
Methods and compositions are provided for treating an ocular disease in a subject in need thereof by increasing the bioavailability of a drug in the subject's eye. In one aspect, the ocular disease is at least one of diabetic retinopathy, macular degeneration, endopthalmitis, glaucoma, cataracts, ocular herpes. The methods and compositions provided herein include an efflux transporter inhibitor and a drug effective for treating the ocular disease. The efflux transporter inhibitor is effective to reduce the efflux of the drug through at least one of P-glycoprotein (Pgp), breast cancer resistant protein (BCRP), and multidrug resistant associated protein 1-9 (MRP1-9).

Method And Composition For Treatment Of Ischemic Neuronal Reperfusion Injury

US Patent:
6462066, Oct 8, 2002
Filed:
Dec 4, 2000
Appl. No.:
09/727707
Inventors:
Harpal S. Mangat - Bala Cynwyd PA
Gerry Ballough - Drexel Hill PA
Gary Brown - Flourtown PA
Assignee:
University of South Florida - Tampa FL
International Classification:
A61K 31445
US Classification:
514398, 514681
Abstract:
Methods and compositions for treatment of, or protection from, neuropathy resulting from reperfusion injury upon reversal of an ischemic condition, comprising treatment or prophylactic treatment of the patient with an antagonist of the type 3 ryanodine receptor, such that a rise in cytosolic Ca concentration is prevented. Therapeutic compositions containing dantrolene or aminodantrolene are administered to the patient to prevent a rise in cytosolic Ca that would otherwise result in Ca -mediated neuronal damage. Treatment of ischemic optic neuropathy by this method is shown, and the methods and compositions presented are also applicable to other ischemic reperfusion neuropathies, such as stroke, reperfusion injury after TPA treatment/carotid endarterectomy, seizures, and excitotoxic retinal damage in glaucoma.

Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury

US Patent:
2016014, May 26, 2016
Filed:
Jan 28, 2016
Appl. No.:
15/009492
Inventors:
Harpal S. Mangat - Potomac MD, US
Pradeep K. Karla - Arlington VA, US
Assignee:
Howard University - Washington DC
International Classification:
A61K 31/4178
Abstract:
A method and composition for the treatment of ischemic neuronal reperfusion injury are provided. The composition can include a compound which is a combination of dantrolene and a residue of FMOC-valine. This composition can be used to provide a faster and higher CNS penetration than heretofore experienced with dantrolene. In another form, dantrolene may be formulated as a pro-drug, a pro-pro-drug and the like.

Method Of Treating An Ocular Disease And Compositions Effective For Treating An Ocular Disease

US Patent:
2015035, Dec 10, 2015
Filed:
Aug 20, 2015
Appl. No.:
14/831030
Inventors:
- Washington DC, US
Harpal S. Mangat - Potomac MD, US
International Classification:
A61K 38/13
A61K 31/573
A61K 38/14
A61K 9/00
A61K 31/546
Abstract:
Methods and compositions are provided for treating an ocular disease in a subject in need thereof by increasing the bioavailability of a drug in the subject's eye. In one aspect, the ocular disease is at least one of diabetic retinopathy, macular degeneration, endopthalmitis, glaucoma, cataracts, ocular herpes. The methods and compositions provided herein include an efflux transporter inhibitor and a drug effective for treating the ocular disease. The efflux transporter inhibitor is effective to reduce the efflux of the drug through at least one of P-glycoprotein (Pgp), breast cancer resistant protein (BCRP), and multidrug resistant associated protein 1-9 (MRP1-9).

Method Of Treating An Ocular Disease And Compositions Effective For Treating An Ocular Disease

US Patent:
2015011, Apr 23, 2015
Filed:
Mar 15, 2013
Appl. No.:
14/395384
Inventors:
- Washington DC, US
Harpal S. Mangat - Washington DC, US
International Classification:
A61K 38/13
A61K 9/00
A61K 31/573
A61K 31/496
A61K 31/546
US Classification:
514 205
Abstract:
Methods and compositions are provided for treating an ocular disease in a subject in need thereof by increasing the bioavailability of a drug in the subjects eye. By one approach, the ocular disease is endophthalmitis. The methods and compositions provided herein include an efflux transporter inhibitor and a drug effective for treating the ocular disease. The efflux transporter inhibitor is effective to reduce the efflux of the drug through at least one of Pglycoprotein (Pgp), breast cancer resistant protein (BCRP), and multidrug resistant associated protein 19 (MRP19). In one aspect, cyclosporine A is the efflux transporter inhibitor.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.